Harry Lander
Directeur Général chez Canary Oncoceutics, Inc.
Fortune : 169 757 $ au 30/06/2024
Profil
Harry M.
Lander is currently the Chief Executive Officer at Canary Oncoceutics, Inc., the Director at Federation Employment & Guidance Service, Inc., and the Director at Capo Therapeutics, Inc. Previously, he held the position of President, Director & Chief Scientific Officer at Zander Therapeutics, Inc. from 2018 to 2019, and President & Chief Scientific Officer at Regen Biopharma, Inc. from 2015 to 2019.
He also served as the Head-Administration at Sidra Medical & Research Center.
In addition, he will be the Chief Scientific Officer at SYBLEU, Inc. from 2022 to 2024.
Dr. Lander obtained his undergraduate degree from Stony Brook University.
He also holds an MBA from The Leonard N Stern School of Business, which he received in 1991.
Furthermore, he earned a doctorate degree from Weill Cornell Graduate School of Medical Sciences in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SYBLEU INC
31,18% | 31/07/2023 | 3 309 000 ( 31,18% ) | 165 450 $ | 30/06/2024 |
REGEN BIOPHARMA, INC.
0,02% | 06/11/2023 | 6 667 ( 0,02% ) | 4 307 $ | 30/06/2024 |
Postes actifs de Harry Lander
| Sociétés | Poste | Début |
|---|---|---|
Federation Employment & Guidance Service, Inc.
 Federation Employment & Guidance Service, Inc. Services to the Health IndustryHealth Services The mission of F·E·G·S Health and Human Services System has remained constant for almost three-quarters of a century: To meet the needs of the Jewish and broader community through a diverse network of high quality, cost-efficient health and human services that help each person achieve greater independence at work, at home, at school and in the community, and meet the ever-changing needs of business and society. F·E·G·S has assisted more than three million people since its founding in 1934 by the Federation of Jewish Philanthropies, now UJA-Federation of New York, of which F·E·G·S is a beneficiary agency. Today, F·E·G·S is one of the largest and most diversified not-for-profit health and human services organizations in the United States. | Directeur/Membre du Conseil | 16/09/2009 |
Capo Therapeutics, Inc.
 Capo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Capo Therapeutics, Inc. develops peptide and epitope vaccines for Alzheimer’s disease. The company is headquartered in Oceanside, CA. | Directeur/Membre du Conseil | - |
Canary Oncoceutics, Inc.
 Canary Oncoceutics, Inc. BiotechnologyHealth Technology Canary Oncoceutics, Inc. develops a precision oncology testing platform. The CEO of the American company is Harry M. Lander. | Directeur Général | - |
Anciens postes connus de Harry Lander
| Sociétés | Poste | Fin |
|---|---|---|
| SYBLEU INC. | Directeur Technique/Scientifique/R&D | 12/04/2024 |
| REGEN BIOPHARMA, INC. | President | 22/01/2019 |
Zander Therapeutics, Inc.
 Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zander Therapeutics, Inc. engages in the development and commercialization of veterinary medical therapies. It focuses on developing small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company was founded on July 18, 2015 and is headquartered in La Mesa, CA. | President | 22/01/2019 |
Sidra Medical & Research Center
 Sidra Medical & Research Center Miscellaneous Commercial ServicesCommercial Services Sidra Medical & Research Center is a state-of-the-art tertiary hospital located in Doha, Qatar that serves women and children. The hospital provides world-class healthcare services and is also a renowned science and research center committed to developing innovative approaches to medical care. | Directeur Administratif | - |
Formation de Harry Lander
| The Leonard N Stern School of Business | Masters Business Admin |
| Stony Brook University | Undergraduate Degree |
| Weill Cornell Graduate School of Medical Sciences | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REGEN BIOPHARMA, INC. | Health Technology |
| SYBLEU INC. | Commercial Services |
| Entreprise privées | 5 |
|---|---|
Federation Employment & Guidance Service, Inc.
Federation Employment & Guidance Service, Inc. Services to the Health IndustryHealth Services The mission of F·E·G·S Health and Human Services System has remained constant for almost three-quarters of a century: To meet the needs of the Jewish and broader community through a diverse network of high quality, cost-efficient health and human services that help each person achieve greater independence at work, at home, at school and in the community, and meet the ever-changing needs of business and society. F·E·G·S has assisted more than three million people since its founding in 1934 by the Federation of Jewish Philanthropies, now UJA-Federation of New York, of which F·E·G·S is a beneficiary agency. Today, F·E·G·S is one of the largest and most diversified not-for-profit health and human services organizations in the United States. | Health Services |
Sidra Medical & Research Center
Sidra Medical & Research Center Miscellaneous Commercial ServicesCommercial Services Sidra Medical & Research Center is a state-of-the-art tertiary hospital located in Doha, Qatar that serves women and children. The hospital provides world-class healthcare services and is also a renowned science and research center committed to developing innovative approaches to medical care. | Commercial Services |
Capo Therapeutics, Inc.
Capo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Capo Therapeutics, Inc. develops peptide and epitope vaccines for Alzheimer’s disease. The company is headquartered in Oceanside, CA. | Health Technology |
Zander Therapeutics, Inc.
Zander Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zander Therapeutics, Inc. engages in the development and commercialization of veterinary medical therapies. It focuses on developing small molecule immunotherapies and cancer stem cell therapies for the veterinary market. The company was founded on July 18, 2015 and is headquartered in La Mesa, CA. | Health Technology |
Canary Oncoceutics, Inc.
Canary Oncoceutics, Inc. BiotechnologyHealth Technology Canary Oncoceutics, Inc. develops a precision oncology testing platform. The CEO of the American company is Harry M. Lander. | Health Technology |
